Teckro’s breakthrough machine learning technology increases the speed and accuracy of clinical trials. Limerick-based life sciences tech firm Teckro has raised $10 million in a Series B round, that brings the amount of funding raised to date to $17.8 million. The latest Series B round was led by Sands Capital Ventures with participation from Bill Maris’ Section 32 venture fund, Founders Fund and private investors.